ST Special Treat (600671.SH) announced that its wholly-owned subsidiary, Huangshan Tianmu Pharmaceutical Co., Ltd. ('Huangshan Tianmu'), recently received the 'Drug Re-registration Approval Notice' issued by the Anhui Provincial Drug Administration. The product is beneficial for nourishing Qi, nourishing the kidneys, nourishing the heart and calming the nerves, and is used for insomnia, dizziness, headaches, palpitations and other symptoms caused by neurosis or other chronic diseases.
ST目药(600671.SH)：安眠补脑颗粒收到药品再注册批准通知书
Special treat pharmaceutical (600671.SH): received notification of drug re-registration approval for Sleep Aid Brain Supplement Granules.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.